AstraZeneca
AZN | NYSE
$186.65
+$12.25 (+7.02%)
At close: Oct 30, 2026, 4:00 PM ET
$186.35
-$0.30 (-0.16%)
After-hours:
Oct 30, 2026, 7:33 PM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
Cash & Equivalents | 5.71B | 5.49B | 5.84B | 6.17B | 6.33B | 7.83B |
Short-Term Investments | 30M | 37M | 20M | 77M | 69M | 160M |
Long-Term Investments | 2.53B | n/a | 1.78B | n/a | n/a | n/a |
Other Long-Term Assets | 9.04B | 3.01B | 5.65B | 2.05B | 2.23B | 2.04B |
Receivables | 15.18B | 11.24B | 8.41B | 9.19B | 8.13B | 5.65B |
Inventory | 6.56B | 5.29B | 5.42B | 4.7B | 8.98B | 4.02B |
Other Current Assets | 1.25B | 2.04B | 3.75B | 1.13B | 1.22B | 142M |
Total Current Assets | 28.72B | 25.83B | 25.05B | 22.59B | 26.24B | 19.54B |
Property-Plant & Equipment | 14.7B | 11.65B | 10.5B | 9.45B | 10.17B | 8.92B |
Goodwill & Intangibles | 59.09B | 58.2B | 58.14B | 59.13B | 62.38B | 32.79B |
Total Long-Term Assets | 85.35B | 78.21B | 76.07B | 73.89B | 79.12B | 47.19B |
Total Assets | 114.07B | 104.04B | 101.12B | 96.48B | 105.36B | 66.73B |
Account Payables | 25.28B | 3.64B | 3.27B | 2.55B | 2.82B | 2.35B |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | 3.19B | 2.16B | 5.13B | 5.23B | 1.57B | 2.19B |
Other Current Liabilities | 686M | 17.31B | 6.13B | 15B | 14.94B | 12.27B |
Total Current Liabilities | 30.62B | 27.87B | 30.54B | 26.29B | 22.59B | 20.31B |
Long-Term Debt | 24.72B | 26.51B | 22.37B | 22.97B | 28.13B | 17.51B |
Other Long-Term Liabilities | 5.1B | 4.37B | 8.15B | 6.48B | 8.36B | 9.83B |
Total Long-Term Liabilities | 34.74B | 35.3B | 31.41B | 33.13B | 43.48B | 30.78B |
Total Liabilities | 65.36B | 63.16B | 61.95B | 59.43B | 66.08B | 51.09B |
Total Debt | 29.7B | 30.11B | 28.62B | 29.14B | 30.69B | 20.38B |
Book Value | 48.72B | 40.87B | 39.17B | 37.06B | 39.29B | 15.64B |
Book Value Per Share | 62.38 | 52.30 | 50.15 | 47.51 | 55.06 | 23.82 |
Common Stock | 388M | 388M | 388M | 387M | 387M | 328M |
Retained Earnings | 10.97B | 3.16B | 4.52B | -574M | 1.71B | 5.3B |
Comprehensive Income | n/a | n/a | n/a | n/a | n/a | n/a |
Shareholders Equity | 48.67B | 40.79B | 39.14B | 37.04B | 39.27B | 15.62B |
Total Investments | 2.56B | 37M | 1.8B | 77M | 69M | 160M |
Add to Watchlist
Select watchlists to add or remove AZN